SEC Form 4 · accession 0001487371-15-000085
GenMark Diagnostics, Inc. · GNMK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Gleeson
Officer — SVP, North American Com. Ops.
Period of report
Jun 3, 2015
Accepted (ET)
Jun 5, 2015 · 6:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001487371
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 3, 2015 | S | 1,255 | $9.47 | D | 183,210 | D | |
| Common Stock | Jun 4, 2015 | S | 340 | $9.83 | D | 182,870 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were sold pursuant to a Rule 10b5-1 trading plan solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock awards and/or units.
- F2The amount reported includes 1,128 shares of the Issuer's common stock acquired under the GenMark Diagnostics, Inc. 2013 Employee Stock Purchase Plan since the reporting person last filed a Form 4 with the Securities and Exchange Commission.